Lithium, pramipexole, bupropion, carbamazepine, valproate, and trazodone. Meds that require special skill to start: 

New data on which psychiatric drug interactions have real clinical impact—and which ones you can stop worrying about.

“When I’m manic, I feel like I put on Superman’s vest.” 

That’s how one patient explained why he didn’t want to stay on lithium. He wasn’t denying the crashes. He just wasn’t ready to give up the highs.
Another described it differently:
“If you take too much of it you're slightly underwater, but if you take too little you're floating three feet above the water.”

It’s gaining popularity as a “natural” form of lithium, but this over-the-counter form has hidden risks.

New studies change how we think about lithium and weight gain, and updates on lumateperone, lavender, and esketamine in depression. 

0.25 CME Credits. In this episode, we explore nine groundbreaking stories in mental health and psychiatric medicine, covering everything from healthcare fraud to the latest advancements in drug trials. First, we dive into the recent charges brought by the US Department of Justice against executives at Done, a California-based telehealth company, for alleged healthcare fraud. Done is accused of prescribing over 40 million Adderall pills to patients without proper evaluation, raising concerns about the balance between increasing mental healthcare access and responsible prescribing practices.